Abstract:Viruses have evolved to traverse cellular barriers and travel to the nucleus by mechanisms that involve active transport through the cytoplasm and viral quirks to resist cellular restriction factors and innate immune responses. Virus-derived vector systems exploit the capacity of viruses to ferry genetic information into cells, and now - more than three decades after the discovery of HIV - lentiviral vectors based on HIV-1 have become instrumental in biomedical research and gene therapies that require genomic insertion of transgenes. By now, the efficacy of lentiviral gene delivery to stem cells, cells of the immune system including T cells, hepatic cells, and many other therapeutically relevant cell types is well established. Along with nucleic acids, HIV-1 virions carry the enzymatic tools that are essential for early steps of infection. Such capacity to package enzymes, even proteins of nonviral origin, has unveiled new ways of exploiting cellular intrusion of HIV-1. Based on early findings demonstrating the packaging of heterologous proteins into virus particles as part of the Gag and GagPol polypeptides, we have established lentiviral protein transduction for delivery of DNA transposases and designer nucleases. This strategy for delivering genome-engineering proteins facilitates high enzymatic activity within a short time frame and may potentially improve the safety of genome editing. Exploiting the full potential of lentiviral vectors, incorporation of foreign protein can be combined with the delivery of DNA transposons or a donor sequence for homology-directed repair in so-called 'all-in-one' lentiviral vectors. Here, we briefly describe intracellular restrictions that may affect lentiviral gene and protein delivery and review the current status of lentiviral particles as carriers of tool kits for genome engineering.

Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy

Lentiviruses as gene transfer agents for delivery to non-dividing cells

Lentiviral vectors

Lentiviral vectors, two decades later

HIV-based vectors: preparation and use

[33] Oncoretroviral and lentiviral vector-mediated gene therapy

Recent Advances in Lentiviral Vectors for Gene Therapy.

In vivo gene delivery by lentiviral vectors

[29] Transduction of a gene expression cassette using advanced generation lentiviral vectors

Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications

[26] Generation of HIV-1 derived lentiviral vectors

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

Application of Lentiviral Vectors in Genetic Engineering

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

Progression and Application of HIV-1-derived Lentivectors

Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years

HIV-1-derived lentiviral vectors

Lentiviral Delivery of Proteins for Genome Engineering

Modulation of immune responses in lentiviral vector-mediated gene transfer

Gene transfer in humans using a conditionally replicating lentiviral vector

Gene Therapy Progress and Prospects: Nonviral vectors